Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Theranostics
|
May 23, 2017
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
Constantin Lapa, Ken Herrmann, Andreas Schirbel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2025
Biodistribution and Radiation Dosimetry for [<sup>68</sup>Ga]Ga-LNTH-1363S, a Probe Targeting Fibroblast Activation Protein α
Johanna S Enke, Bradley W Schuller, Lisa Glantschnig, et al.
Acta Neuropathologica
|
January 27, 2026
FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study
Nic G Reitsam, Alexander Gäble, Lisa Siebenhüter, et al.
Cancers
|
July 29, 2023
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target
Feyza Şen, Gabriel T Sheikh, Johannes von Hinten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Johanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 3, 2024
Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&T
Alexander Gäble, Alexander Dierks, Andreas Rinscheid, et al.
Cancers
|
August 28, 2020
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CT
Xiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Scientific Reports
|
December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation
Jens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Johannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Theranostics
|
August 15, 2022
Reduced splenic uptake on <sup>68</sup>Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis
Sabrina Kraus, Philipp Klassen, Malte Kircher, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Theranostics
|
May 23, 2017
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
Constantin Lapa, Ken Herrmann, Andreas Schirbel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2025
Biodistribution and Radiation Dosimetry for [<sup>68</sup>Ga]Ga-LNTH-1363S, a Probe Targeting Fibroblast Activation Protein α
Johanna S Enke, Bradley W Schuller, Lisa Glantschnig, et al.
Acta Neuropathologica
|
January 27, 2026
FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study
Nic G Reitsam, Alexander Gäble, Lisa Siebenhüter, et al.
Cancers
|
July 29, 2023
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target
Feyza Şen, Gabriel T Sheikh, Johannes von Hinten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Johanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 3, 2024
Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&T
Alexander Gäble, Alexander Dierks, Andreas Rinscheid, et al.
Cancers
|
August 28, 2020
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CT
Xiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Scientific Reports
|
December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation
Jens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Johannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Theranostics
|
August 15, 2022
Reduced splenic uptake on <sup>68</sup>Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis
Sabrina Kraus, Philipp Klassen, Malte Kircher, et al.
Page
of 6